Delivery Order SPE2DB24D2205-SPE2DB25FEGDC
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,510.52 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for TREMFYA 200 mg/2 mL pen injections. This contract, classified as a firm fixed price delivery order with no set-aside designation, is scheduled for completion by September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic immunosuppressant medication used to treat psoriasis and psoriatic...
- The Defense Logistics Agency awarded a $19,499.34 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $9,132.68 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and...
- The Defense Logistics Agency awarded a delivery order valued at $13,888.78 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML syringes on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is an injectable immunosuppressant medication used to treat psoriasis and psoriatic...
- The Defense Logistics Agency awarded a $14,539.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL syringes. This order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat psoriasis and psoriatic arthritis, indicating this delivery supports...
- The Defense Logistics Agency awarded a delivery order valued at $7,269.70 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TREMFYA 200 mg/2 ml syringes. This competitive, non-set-aside contract has a firm fixed price structure with an ultimate completion date of September 4, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used in the treatment of plaque psoriasis and psoriatic arthritis, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes valued at $7,683.48 on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a specialty immunosuppressant injection used to treat psoriasis and psoriatic arthritis, reflecting the...
- The Defense Logistics Agency awarded a $29,944.86 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania facility. TREMFYA is a biologic medication used primarily for treating moderate-to-severe plaque psoriasis and is being procured to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of TREMFYA 100 mg/mL in pen format, with a contract ceiling value of $30,669.82. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...